Citations 9

Reinterpretation of outside imaging and review at hepatobiliary tumor board: impact on diagnosis and management of patients with hepatobiliary neoplasms

No container title available | April 7, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-6221151/v1

Abstract Objectives: Radiologist participation in multidisciplinary tumor board can be time-consuming and demanding, requiring substantial preparation. Anecdotally radiologist participation is felt to help identify discrepancies in previous interpretations; however, there are limited data assessing the actual impact of their tumor board review on patient management. This prospective study aims to evaluate how the reinterpretation of outside imaging and review at hepatobiliary tumor board (HBTB) affects the diagnosis and management of patients with hepatobiliary neoplasms. Methods: This prospective analysis included all patients presented at the weekly HBTB between 6/13/2023 - 6/25/2024. One radiologist reviewed the available reports of outside imaging, the local reinterpretation of outside imaging, the updated local imaging, and documented conclusions from discussion of the case at HBTB. HBTB included 4 radiologists who had reviewed each case. Discrepancies (presence/absence, number, and reasons for) were recorded. When discrepancies occurred, the impact on patient management (5-point Likert scale) was determined by two of the radiologists present at the HBTB in consensus, with input from clinicians if needed. A six-month follow-up was performed to confirm suspected diagnoses. Results: 208 cases (128 males, 104 chronic liver disease patients) were presented at HBTB. Disagreements in the detection or characterization of lesions were found in 59/208 (28.4%) of cases. A change in management occurred in 38/59 (64.6%) of these discrepant cases. In cases with recorded discrepancies in which follow-up confirmation was available, the final interpretation was confirmed in 34/41 (82.9%) of cases. Conclusion: Our study found a discrepant interpretation in nearly one-third of cases presented at a weekly HBTB and a resultant change in management in 65% of those cases. These findings highlight the importance of reinterpretation of prior imaging studies and the presence of radiologists at HBTB to guide optimal patient management.
Concurrent Chest and Abdominal CT: Managing Pitfalls of Splitting Interpretation by Subspecialty

RadioGraphics | February 13, 2025 | Volume: 45 | Issue: 3 | Pages: No page available

10.1148/rg.240069 | PMID 39946263

Dividing the interpretation of concurrently acquired chest and abdominal CT images between two radiologists has advantages, and the potential problems can be mitigated by awareness, defined expectations, and communication.
Diffusely Infiltrative Small Bowel Disease

RadioGraphics | August 29, 2024 | Volume: 44 | Issue: 9 | Pages: No page available

10.1148/rg.230148 | PMID 39207924

Imaging Features in the Liver after Stereotactic Body Radiation Therapy

RadioGraphics | October 14, 2022 | Volume: 42 | Issue: 7 | Pages: 2131-2148

10.1148/rg.220084 | PMID 36240077

Imaging Review of Gastrointestinal Motility Disorders

RadioGraphics | October 7, 2022 | Volume: 42 | Issue: 7 | Pages: 2014-2036

10.1148/rg.220052 | PMID 36206184

Imaging of Bowel Ischemia: An Update, From the AJR Special Series on Emergency Radiology

American Journal of Roentgenology | August 10, 2022 | Volume: 220 | Issue: 2 | Pages: 173-185

10.2214/ajr.22.28140 | PMID 35946859

Hepatocellular Carcinoma Screening at Transplant Centers: Counterpoint—CT and MRI Are the Way to Go

American Journal of Roentgenology | August 19, 2020 | Volume: 216 | Issue: 3 | Pages: 581-582

10.2214/ajr.20.24252 | PMID 32812801

Anaphylactic reaction to an ultrasound contrast agent (Lumason) in a patient with systemic mastocytosis

Journal of Clinical Ultrasound | March 8, 2018 | Volume: 46 | Issue: 8 | Pages: 533-535

10.1002/jcu.22585 | PMID 29517164

AbstractSevere adverse reactions to ultrasound (US) contrast agents are rare, and only a few cases of anaphylaxis following the administration of US contrast agents have been reported, often without a defined etiology. We present a case of anaphylactic reaction to the injection of an US contrast agent in a patient with systemic mastocytosis, which highlights the disorder as a possible risk factor warranting additional consideration prior to performing a contrast‐enhanced US examination.
Safety and Accuracy of Percutaneous Image-Guided Core Biopsy of the Spleen

American Journal of Roentgenology | February 22, 2016 | Volume: 206 | Issue: 3 | Pages: 655-659

10.2214/ajr.15.15125 | PMID 26901024